Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
59.70
+0.64 (+1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Exact Sciences Shares Drop After Guiding Lower Screening Revenue For FY21
November 03, 2021
Exact Sciences Corp's (NASDAQ: EXAS) Q3 revenues rose 12% Y/Y to $456.4 million, beating the consensus of $430.03 million. The increase is attributable to increased...
Via
Benzinga
Exact Sciences (EXAS) Q3 2021 Earnings Call Transcript
November 03, 2021
EXAS earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
Why Exact Sciences' Stock Is Trading Higher Today
September 15, 2021
Exact Sciences (NASDAQ:EXAS) shares are trading higher after the company announced an expansion of its primary care sales team with the addition of former Pfizer sales...
Via
Benzinga
Unusual Options Activity Insight: Exact Sciences
August 13, 2021
Exact Sciences (NASDAQ:EXAS) shares experienced unusual o...
Via
Benzinga
Unusual Options Activity Insight: Exact Sciences
August 03, 2021
On Tuesday, shares of Exact Sciences (NASDAQ:EXAS) saw un...
Via
Benzinga
Expert Ratings for Exact Sciences
July 29, 2021
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the fol...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
3 Crash-Ready Stocks to Buy in September
September 14, 2021
History says this month can be scary. These stocks can get you through it.
Via
The Motley Fool
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused...
Via
Benzinga
3 Top Healthcare Stocks to Buy for August
August 19, 2021
With excellent prospects, these three companies are built to last and today's prices are attractive.
Via
The Motley Fool
44 Stocks Moving In Thursday's Mid-Day Session
July 29, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Why Exact Sciences Is Trading Higher Today
May 20, 2021
Exact Sciences Corp (NASDAQ:EXAS) is trading higher Thursd...
Via
Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving in Thursday's Pre-Market Session
July 29, 2021
Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer...
Via
Benzinga
Exact Sciences (EXAS) Q2 2021 Earnings Call Transcript
July 29, 2021
EXAS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
10 Stocks Moving In Wednesday's After-Hours Session
July 28, 2021
Gainers Qualcomm (NASDAQ: QCOM) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 EPS guidance above estimates....
Via
Benzinga
Why PAVmed Soared by 12% on Wednesday
July 28, 2021
The company tapped a respected figure in its industry as a board vice chairman.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 28, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS
Via
Benzinga
Exact Sciences: Q2 Earnings Insights
July 28, 2021
Shares of Exact Sciences (NASDAQ:EXAS) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 77.59% over the...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Unusual Options Activity Insight: Exact Sciences
July 14, 2021
Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Wednesday. The stock price moved down to $112.83 following the option alert. Sentiment: BULLISH...
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 21, 2021
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
Cramer Gives His Opinion On Novavax, Exact Sciences And More
June 08, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Moderna Inc (NASDAQ: MRNA) over Novavax, Inc. (NASDAQ: NVAX). Philip Morris International Inc. (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
June 03, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Why Exact Sciences Stock Soared Today
May 20, 2021
The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.
Via
The Motley Fool
Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why
May 20, 2021
Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection.
Via
Investor's Business Daily
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.